Inside Innovation

Immusoft, a Seattle-based biotech has announced a partnership with Takeda to create treatments for rare neurometabolic conditions. As a result of the $900 million deal,

Local Seattleite Trevor Bedford has been selected as a recipient of the John D. and Catherine T. MacArthur Foundation’s annual MacArthur Fellowship, which awards funding

As previously announced, Dr. Leslie Alexandre will be stepping down from her role as President and CEO of Life Science Washington at the end of

Absci announced a new partnership with EQRx, a Cambridge, Massachusetts pharmaceutical company focused on developing lower-cost medicines. The two companies plan to jointly engineer and

LPC West and Invesco Real Estate have purchased a nine-story building in South Lake Union, known as Cascadian, for $164.5 million with the intention of

The Howard Hughes Medical Institute (HHMI) has recognized 33 scientists across the U.S. for outstanding scientific research, rewarding them with a total of $300 million.

In September, several life sciences companies attended the East West Life Science Summit hosted by Life Science Washington, discussing the many benefits to starting their

Adaptive Biotechnologies, a Seattle-based biotech company founded to search for cures to cancer, is now expanding its mission to develop solutions to fight COVID-19 by

Alpine Immune Sciences announced it is raising approximately $91 million to continue developing two drugs through a private placement. Frazier Life Sciences Public Fund is

A-Alpha Bio, a Seattle-based startup raised $20 million in a Series A funding round to continue studying which proteins bind with each other. Moving forward

Impel NeuroPharma announced Trudhesa, a drug used to treat migraines, has officially received approval from the U.S. Food and Drug Administration. John Hoekman originally co-founded

During an era of mass investment in the biotech industry and vast innovation, many technology company executives are making the switch to the life science